Mind Medicine (NASDAQ: MNMD) stock is seeing impressive gains Friday. The company's share price was up 16.9% as of 3:15 p.m. ET and had been up as much as 20.7% on the day earlier in the session. Mind ...

Recent discussions on X about Mind Medicine (MindMed) stock, listed as MNMD, have been buzzing with interest following news of growing political momentum for psychedelic therapies. Many users are ...

Late on Monday, Connecticut's House of Representatives approved a bill to decriminalize psilocybin, the psychoactive compound found in so-called "magic" mushrooms. The vote was narrow, with 74 of the ...

Mind Medicine recently launched a Phase 3 trial of MM120 in GAD and expanded its intellectual property protection through 2041 by obtaining a patent for an orally disintegrating tablet (ODT) ...

Investors might want to bet on Mind Medicine (MindMed) Inc. (MNMD), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...

Back in 2024, on May 14, a caller brought up Mind Medicine (MindMed) Inc. (NASDAQ:MNMD), a biotech company focused on psychedelic treatments for mental health. Cramer said he was supportive back then, ...

Needham initiated coverage on Mind Medicine Inc. (NASDAQ:MNMD), or MindMed, on Monday. The late-stage clinical biopharmaceutical company is developing novel product candidates to treat brain health ...

Mind Medicine (NASDAQ: MNMD) stock is posting big gains in Tuesday's trading. The biotech company's share price was up 8.7% as of 2 p.m. ET despite a 0.8% pullback for the S&P500 index and a 1.5% ...